Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L, Andreadis A, Wiederholt WC, Raskind M, Schellenberg GD (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 43:815–825

Article  CAS  PubMed  Google Scholar 

Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A et al (1998) Association of missense and 5’-splice site mutations in tau with the inherited dementia FTDP-17. Nature 393:702–705

Article  CAS  PubMed  Google Scholar 

Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 95:7737–7741

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kovacs GG, Ghetti B, Goedert M (2023) Tau Proteinopathies. In: Greenfield’s Neuropathology, 10th Edition (C Smith, T Jacques, GG Kovacs and A Perry, eds). CRC Press, Boca Raton, in press

Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer’s disease. Neuron 3:519–526

Article  CAS  PubMed  Google Scholar 

Goedert M, Eisenberg DS, Crowther RA (2017) Propagation of tau aggregates and neurodegeneration. Annu Rev Neurosci 40:189–210

Article  CAS  PubMed  Google Scholar 

Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, van Slegtenhorst M, Gwinn-Hardy K, Murphy M, Baker M, Yu X et al (2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 25:402–405

Article  CAS  PubMed  Google Scholar 

Götz J, Chen F, Barmettler R, Nitsch RM (2001) Tau filament formation in transgenic mice expressing P301L tau. J Biol Chem 276:529–534

Article  PubMed  Google Scholar 

Allen B, Ingram E, Takao M, Smith MJ, Jakes R, Virdee K, Yoshida H, Holzer M, Craxton M, Emson PC et al (2002) Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J Neurosci 22:9340–9351

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TC, Maeda J, Suhars T, Trojanowski JQ, Lee VMY (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53: 553–571 (2007)

Bugiani O, Murrell JR, Giaccone G, Hasegawa M, Ghigo G, Tabaton M, Morbin M, Primavera A, Carella F, Solaro C et al (1999) Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol 58:667–677

Article  CAS  PubMed  Google Scholar 

Sperfeld AD, Collatz MB, Baier H, Palmbach M, Storch A, Schwarz J, Tatsch K, Reske S, Joosse M, Heutink P et al (1999) FTDP-17: an early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation. Ann Neurol 46:708–715

Article  CAS  PubMed  Google Scholar 

Yasuda M, Yokoyama K, Nakayasu T, Nishimura Y, Matsui M, Yokoyama T, Miyoshi K, Tanaka C (2000) A japanese patient with frontotemporal dementia and parkinsonism by a tau P301S mutation. Neurology 55:1224–1227

Article  CAS  PubMed  Google Scholar 

Lossos A, Reches A, Gal A, Newman JP, Soffer D, Gomori JM, Boher M, Ekstein D, Biran I, Meimner Z et al (2003) Frontotemporal dementia and parkinsonism with the P301S tau gene mutation in a Jewish family. J Neurol 250:733–740

Article  CAS  PubMed  Google Scholar 

Werber E, Klein C, Grünfeld J, Rabey JM (2003) Phenotypic presentation of frontotemporal dementia with parkinsonism-chromosome 17 type P301S in a patient of Jewish-Algerian origin. Mov Disord 18:595–598

Article  PubMed  Google Scholar 

Yasuda M, Nakamura Y, Kawamata T, Kaneyuki H, Maeda K, Komure O (2005) Phenotypic heterogeneity within a new family with the MAPT P301S mutation. Ann Neurol 58:920–928

Article  CAS  PubMed  Google Scholar 

Goedert M, Jakes R, Crowther RA (1999) Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments. FEBS Lett 450:306–311

Article  CAS  PubMed  Google Scholar 

D’Souza I, Poorkaj P, Hong M, Nochlin D, Lee VMY, Bird TD, Schellenberg GD (1999) Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism – chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc Natl Acad Sci USA 96:5598–5603

Article  PubMed  PubMed Central  Google Scholar 

Delobel P, Lavenir I, Fraser G, Ingram E, Holzer M, Ghetti B, Spillantini MG, Crowther RA, Goedert M (2008) Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy

Velasco A, Fraser G, Delobel P, Ghetti B, Lavenir I, Goedert M (2008) Detection of filamerntous tau inclusions by the fluorescent Congo red derivative [(trans, trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene]. FEBS Lett 582: 901–906 (2008)

Macdonald JA, Bronner IF, Drynan L, Fan J, Curry A, Fraser G, Lavenir I, Goedert M (2019) Assembly of transgenic human P301S tau is necessary for neurodegeneration in murine spinal cord. Acta Neuropathol Commun 7:44

Article  PubMed  PubMed Central  Google Scholar 

Yang Y, Arseni D, Zhang W, Huang M, Lövestam S, Schweighauser M, Kotecha A, Murzin AG, Peak-Chew SY, Macdonald J et al (2022) Cryo-EM structures of amyloid-β 42 filaments from human brains. Science 375:167–172

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goedert M, Spillantini MG, Cairns NJ, Crowther RA (1992) Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8:159–168

Article  CAS  PubMed  Google Scholar 

Falcon B, Zhang W, Murzin AG, Murshudov G, Garringer HJ, Vidal R, Crowther RA, Ghetti B, Scheres SHW, Goedert M (2018) Structures of filaments from Pick’s disease reveal a novel tau protein fold. Nature 561:137–140

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dan A, Takahashi M, Masuda-Suzukake M, Kametani F, Nonaka T, Kondo H, Akiyama H, Arai T, Mann DMA, Saito Y et al (2013) Extensive deamidation at asparagine residue 279 accounts for weak immunoreactivity of tau with RD4 antibody in Alzheimer’s disease brain. Acta Neuropathol Commun 1:54

Article  PubMed  PubMed Central  Google Scholar 

Taniguchi-Watanabe S, Arai T, Kametani F, Nonaka T, Masuda-Suzukake M, Tarutani A, Murayama S, Saito Y, Arima K, Yoshida M et al (2016) Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau. Acta Neuropathol 131:267–280

Article  CAS  PubMed  Google Scholar 

He S, Scheres SHW (2017) Helical reconstruction in RELION. J Struct Biol 193:163–176

Article  Google Scholar 

Zivanov J, Nakane T, Forsberg BO, Kimanius D, Hagen WJ, Lindahl E, Scheres SHW (2018) New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife 7:e42166

Article  PubMed  PubMed Central  Google Scholar 

Rohou A, Grigorieff N (2015) CTFFIND4: fast and accurate defocus estimation from electron micrographs. J Struct Biol 192:216–221

Article  PubMed  PubMed Central  Google Scholar 

Scheres SHW (2020) Amyloid structure determination in RELION-3.1. Acta Cryst D 76:94–101

Article  CAS  Google Scholar 

Zivanov J, Otón J, Ke Z, von Kügelen A, Pyle E, Qu K, Morado D, Castaño-Diez D, Zanetti G, Bharat TAM et al (2022) A Bayesian approach to single-particle electron cryo-tomography in RELION-4.0. eLife 11:e83724

Article  PubMed  PubMed Central  Google Scholar 

Scheres SHW, Chen S (2012) Prevention of overfitting in cryo-EM structure determination. Nat Meth 9:853–854

Article  CAS  Google Scholar 

Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta Crystallogr D 66:486–501

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yamashita K, Palmer CM, Burnley T, Murshudov GN (2021) Cryo-EM single-particle structure refinement and map calculation using Servalcat. Acta Crystallogr D 77:1282-1291

Murshudov GN, Vagin AA, Dodson EJ (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D 53:240–255

Article  CAS  PubMed  Google Scholar 

Murshudov GN, Skubák P, Lebedev AA, Pannu NS, Steiner RA, Nicholls RA, Winn MD, Long F, Vagin AA (2011) REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr D 67:355–367

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen VB, Arendall WB, Headd JJ, Keedy DA, Immormino RM, Kaprai GJ, Murray LW, Richardson JS, Richardson DC (2010) MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D 66:12–21

Article  CAS  PubMed  Google Scholar 

Pettersen EF, Goddard TD, Huang CC, Meng EC, Couch GS, Croll TI, Morris JH, Ferrin TE (2021) ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci 30:70–82

Article  CAS  PubMed  Google Scholar 

Schrödinger L, DeLano W (2020) PyMOL available at: http//www.pymol.org/pymol

Woerman AL, Patel S, Kazmi SA, Oehler A, Freyman Y, Espiritu L, Cotter R, Castaneda JA, Olson SH, Prusiner SB (2017) Kinetics of human mutant tau prion formation in the brains of 2 transgenic mouse lines. JAMA Neurol 74:1464–1472